
Akebia Therapeutics
Development and commercialization of therapeutics for patients with chronic kidney disease.
HQ location
Cambridge, United States
Website
Launch date
Employees
Market cap
$957m
Authorizing premium user...
Development and commercialization of therapeutics for patients with chronic kidney disease.